Covid-19 in the US is a ‘humanitarian disaster,’ and the pandemic is only accelerating, experts say
Pfizer‘s CEO Dumps 62% Of His Stock On COVID Vaccine Announcement
Pfizer‘s CEO cashed out 60% of his stock on the same day the company unveiled the results of its COVID-19 vaccine trial
https://twitter.com/AlbertBourla
“The sale of these shares is part of Dr. Bourla’s personal financial planning and a pre-established (10b5-1) plan, which allows, under SEC rules, major shareholders and insiders of exchange-listed corporations to trade a predetermined number of shares at a predetermined time,” the company said. Mr Bourla, who still has 81,812 shares in the company.
Pfizer CEO Sells Stock Same Day as Vaccine Announcement – it doesn’t matter that this was scheduled to happen, that it he knew all about the everything first before he announced it then allowed the scheduled sale to just happen anyway was awful optics! just makes you look so so selfish Albert!
#DELETEFOX Fox news now has to head into a post-Trump era

The Real Facebook Oversight Board @FBoversight
Overnight, The Real Facebook Oversight Board observed a “Stop The Steal” private Facebook group gain 19,000 followers even after Facebook said they had removed all “Stop The Steal” accounts.
Suckerburg loves trump and loves them FB money from all the FB vidiots that can’t seem to think for themselves.
Daniel Taylor, an expert in insider trading and an associate professor of accounting at the Wharton School of the University of Pennsylvania, has closely monitored stock trades by executives at companies developing coronavirus vaccines. He told NPR that the close timing between the adoption of Bourla’s stock plan and the press release looked “very suspicious.”
“It’s wholly inappropriate for executives at pharmaceutical companies to be implementing or modifying 10b5-1 plans the business day before they announce data or results from drug trials,” Taylor said.
https://www.npr.org/2020/11/11/933957580/pfizer-ceo-sold-millions-in-stock-after-coronavirus-vaccine-news-raising-questio